U.S. experience of transradial coronary stenting utilizing Palmaz-Schatz stents
โ Scribed by El-Shiekh, Reda A. ;Burket, Mark W. ;Mouhaffel, Assad ;Moore, Joseph A. ;Cooper, Christopher J.
- Publisher
- John Wiley and Sons
- Year
- 1997
- Tongue
- English
- Weight
- 76 KB
- Volume
- 40
- Category
- Article
- ISSN
- 0098-6569
No coin nor oath required. For personal study only.
โฆ Synopsis
Transradial coronary stenting has been associated with a low frequency of vascular complications and shortened hospital length of stay, but few reports of safety and feasibility are available. To determine the safety and efficacy of transradial coronary stenting, our initial experience in 38 patients was reviewed. Palmaz-Schatz stents hand-mounted on Predator (Cordis Corp., Miami Lakes, FL) balloons were delivered through 6 Fr guide catheters. In 1 of 38 patients (3%) radial access could not be achieved. Fifty-five stents were implanted in 44 lesions (3 total occlusion, 18 type A, 19 type B, 9 type C, National Heart Lung Blood Institute Classification). Access time was 7.7 6 4.6 min. Procedural success was achieved in 36 patients (97%). In one patient, a stent could not be delivered to a distal circumflex lesion due to marked proximal tortuosity and calcification. Poststenting residual stenosis was 0 6 10%. No access-related complications occurred. One patient had stent thrombosis and required repeat angioplasty and stenting. We conclude that transradial coronary stenting is both feasible and safe with a low risk of access complications and with excellent procedural results.
๐ SIMILAR VOLUMES
Wiktor-GX coil stents and Palmaz-Schatz 154A tubular stents were implanted in a consecutive series of 40 patients and 45 arteries undergoing successful primary stent placement in de novo lesions treated with single stents in order to compare the acute recoil of a coil stent to a tubular stent in nat
A 64-year-old patient with silent myocardial ischemia after anterior myocardial infarction was treated with directional coronary atherectomy, balloon angioplasty, and placement of Palmaz-Schatz stent. An unexpanded Palmaz-Schatz stent was retained in the left main coronary artery and was treated suc
Acute and long-term (>/= 3 years) outcomes of coronary artery stenting using Palmaz-Schatz and Multi-Link stent implantations between November 1995 and October 1999 were analyzed. There were 655 Palmaz-Schatz stent implantations in 577 lesions on 477 patients (group A) and 428 Multi-Link stent impla